Advocacy Involvement
Forging the path for the psychedelic industry does not just mean deploying capital into the industry,
it also means actively participating in legal reform, advocacy, and community building.
The Iter Investments team has leadership roles in various non-profits to help build the future of the psychedelic industry.
-
Mr. Psychedelic Law
Managing Partner Dustin Robinson and Clinical Lead Michelle Weiner founded Mr. Psychedelic Law, a 501(c)(4) to drive responsible legal reform of psilocybin mushrooms toward improving mental health outcomes for all. It has a Medical and Legal Advisory Board with the top medical and legal minds in the psychedelic industry.
-
MindArmy
Managing Partner Dustin Robinson co-founded MindArmy, a 501(c)(3) that is demanding that the federal government de-schedule psychedelics so that humans can go inside our own mind for answers and healing during this Mental Health Crisis.
-
TheraPsil
Intellectual Property Lead David Wood represents TheraPsil, a non-profit coalition dedicated to obtaining legal access to psilocybin-assisted psychotherapy for terminally ill Canadians. TheraPsil’s mission includes facilitating and promoting compassionate access to psilocybin for therapeutic use, public education, professional training, and research.
-
Psychedelic Pharmacists Association
Managing Partner Dustin Robinson’s law firm represents Psychedelic Pharmacists Association – a non-profit devoted to pharmacists advancing psychedelics as medicines. The organization’s vision is to serve as the premier resource for pharmacists in advancing psychedelic therapies.
Iter’s collaboration with Non-Profit Organizations and Social Impact Programs builds mental health awareness, advocacy, drives policy change.
Driving innovation through partnerships across the psychedelic ecosystem